LEKAPHARM A/S — Credit Rating and Financial Key Figures

LEKAPHARM A/S (CVR number: 32945945) is a company from FAABORG-MIDTFYN. The company recorded a gross profit of 6178.7 kDKK in 2024. The operating profit was 3235.3 kDKK, while net earnings were 2051.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 20.5 %, which can be considered excellent and Return on Equity (ROE) was 34.6 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 30.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. LEKAPHARM A/S's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.